Interv Akut Kardiol. 2010;9(2):70-74
Catheter ablation for atrial fibrillation (AF) has gained wide acceptance as an important therapeutic modality for the treatment of
patients with symptomatic recurrent AF. According to several randomized trials, catheter ablation for AF is superior to continuing pharmacologic
treatment when at least one antiarrhythmic drug failed to control the AF. In these studies, the ablation strategy resulted to
freedom from AF recurrence, improvement in AF burden and improvement in quality of life. However, because catheter ablation for
AF is a demanding technical procedure that may result in serious complications, patients should only undergo AF ablation after carefully
weighing the risks and benefits of the procedure. Meticulous clinical approach is required to identify the patients most likely to
respond to catheter ablation. Not only diligently performed ablation procedure but also pre- and post-procedural management of patients
in collaboration with referring physicians is crucial for final clinical success. The randomized controlled studies are ongoing aimed
at establishing AF ablation as first-line treatment and demonstrating that the effect of catheter ablation for AF translates into improved
clinical outcomes and reduction in overall mortality.
Published: April 1, 2010 Show citation